Viral receptors are host cell surface molecules or proteins that viruses specifically recognize and bind to during the initial stages of infection. The interaction between viral proteins and cellular receptors is a critical step in the viral life cycle, facilitating the entry of the virus into the host cell. Different viruses exhibit specificity for particular receptors, and the presence or absence of these receptors on the host cell surface determines the permissibility of infection. Receptors can vary widely, ranging from proteins on the cell membrane to molecules involved in cellular signaling pathways. The binding of a virus to its receptor triggers conformational changes in viral proteins, facilitating the fusion of the viral envelope with the host cell membrane or the internalization of the virus through endocytosis. Understanding viral receptors is essential for unraveling the mechanisms of viral entry, identifying potential targets for antiviral drugs, and developing strategies to block or disrupt viral infections. Research in viral receptor biology contributes to our understanding of host-virus interactions, guiding the development of therapeutic interventions and vaccines aimed at preventing or treating viral diseases.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe